According to the SEC Form 4 filings, STARR CHRISTOPHER M, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $659,387 | 1 | 100 |
| 2026-10-01 | Sale | Monopar Therapeutics Inc. MNPR | director | 8,400 0.099% | $78.50 | $659,387 | -7.21% | |
| 2025-07-14 | Sale | Monopar Therapeutics Inc. MNPR | director | 16,800 0.2513% | $40.00 | $672,020 | +40.7% | |
| 2005-12-01 | Sale | BioMarin Pharmaceutical Inc. BMRN | SVP, Chief Scientific Officer | 10,571 0.0148% | $10.00 | $105,710 | +32.85% | |
| 2005-11-21 | Sale | BioMarin Pharmaceutical Inc. BMRN | SVP, Chief Scientific Officer | 5,000 0.0069% | $10.00 | $50,000 | +28.44% | |
| 2004-06-03 | Sale | BioMarin Pharmaceutical Inc. BMRN | SVP, Chief Scientific Officer | 10,000 0.0183% | $7.61 | $76,100 | -14.65% | |
| 2004-04-02 | Sale | BioMarin Pharmaceutical Inc. BMRN | SVP, Chief Scientific Officer | 5,570 0.0044% | $4.00 | $22,280 | -29.28% | |
| 2004-04-01 | Sale | BioMarin Pharmaceutical Inc. BMRN | SVP, Chief Scientific Officer | 5,000 0.0077% | $7.56 | $37,795 | -26.63% | |
| 2003-08-21 | Sale | BioMarin Pharmaceutical Inc. BMRN | SVP, Chief Scientific Officer | 33,000 0.0517% | $9.00 | $297,000 | -18.33% | |
| 2003-07-15 | Sale | BioMarin Pharmaceutical Inc. BMRN | SVP, Chief Scientific Officer | 33,000 0.0521% | $10.11 | $333,630 | -23.98% |